Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

期刊论文
出版模式：

开放获取
发表日期：

2025年4月24日

查看全文

Diana Cirstea,
Rajib Shome,
Mehmet Samur,
Srikanth Talluri,
Joseph J. Connolly,
Alexandra Jean Wright,
Emilie Duvallet,
Amanda N. R. Joyce,
Kathleen Lively,
Gina Basinsky,
Andrew J. Yee,
Cristiana Costa Chase,
Ehsan Malek,
Ruben Niesvizky,
Paul G. Richardson,
Noopur S. Raje

本文未提供摘要，请点击“查看全文”查看完整内容。